REVEL PHARMACEUTICALS
Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes. It is commercializing therapeutic enzymes to degrade age-associated molecule damage.
REVEL PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.revelpharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
+1 217 766 4292
Total Funding:
8.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Nginx Google Apps For Business AJAX Libraries API Google
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
KIZOO Technology Capital
KIZOO Technology Capital investment in Seed Round - Revel Pharmaceuticals
Starbloom Capital
Starbloom Capital investment in Seed Round - Revel Pharmaceuticals
Tubus
Tubus investment in Seed Round - Revel Pharmaceuticals
Official Site Inspections
http://www.revelpharmaceuticals.com
- Host name: ec2-18-208-88-157.compute-1.amazonaws.com
- IP address: 18.208.88.157
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Revel Pharmaceuticals"
Revel Pharmaceuticals
Many diseases are caused by the excess accumulation of a toxic protein or metabolite. Revel develops therapies to repair the damage, and reverse the course of disease.See details»
About Us - Revel Pharmaceuticals
Revel Pharmaceuticals operates out of Mission Bay in the San Francisco Bay Area - an emerging hub of the next generation of biotechnology unicorns. We pride ourselves on our team …See details»
Revel Pharmaceuticals - Crunchbase Company Profile & Funding
View contacts for Revel Pharmaceuticals to access new leads and connect with decision-makers. Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney …See details»
Revel Pharmaceuticals - LinkedIn
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological, age associated compounds known as Advanced...See details»
Kizoo Portfolio Company Revel Pharmaceuticals Announces
SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) -- Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today …See details»
Revel Pharmaceuticals Launched - SENS Research …
Jan 21, 2020 · Revel Pharmaceuticals is a biotechnology company located in San Francisco, CA. with a technology platform based on the work of Yale Professors David Spiegel and Jason Crawford. We are commercializing therapeutic …See details»
Revel Pharmaceuticals | Repairing damage from aging at the …
Repairing damage from aging at the molecular level. Learn More.See details»
Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M …
SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) -- Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today …See details»
Revel Pharmaceuticals - Overview, News & Similar companies
View Revel Pharmaceuticals (www.revelpharmaceuticals.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Revel Pharmaceuticals - PitchBook
Developer of proprietary enzyme discovery and engineering platform intended to produce therapeutics to degrade age-associated molecule damage.See details»
Kizoo Portfolio Company Revel Pharmaceuticals …
Mar 17, 2022 · San Francisco, CA, U.S., – Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today that it has raised $8.4M in Seed financing.See details»
Revel Pharmaceuticals - Products, Competitors, Financials, …
Revel Pharmaceuticals is a biotechnology company focused on the commercialization of therapeutic enzymes within the healthcare industry.See details»
Revel Pharmaceuticals’ seed round for anti-aging drugs
Jan 21, 2020 · San Francisco based biotech start-up Revel Pharmaceuticals has announced itself to the world after securing an undisclosed amount of seed funding. Revel is co-founded by …See details»
Revel announces $8.4m for repairing-based approaches to …
Mar 17, 2022 · Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today that it has raised $8.4M in Seed financing.See details»
Technology - Revel Pharmaceuticals
We focus on diseases with unmet clinical need, a clear mechanism of action (MOA), and for which an enzyme therapy is the most efficacious therapeutic modality. Revel develops therapies to …See details»
Revel Pharmaceuticals Finally Seed Funded to Develop …
Jan 7, 2020 · Revel Pharmaceuticals is the biotech startup established to develop glucosepane cross-link breaker drugs based on work carried out by the Spiegel Lab at Yale. That team, …See details»
Revel Pharmaceuticals Announces $8.4-Million Seed to Develop …
Revel Pharmaceuticals recently announced it has raised $8.4 million in seed financing. The oversubscribed round was led by Kizoo Technology Capital, a leading early stage investor in …See details»
Kizoo Portfolio Company Revel Pharmaceuticals Announces $8
Mar 17, 2022 · San Francisco, CA, U.S., March 17, 2022 – Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today …See details»
Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M …
SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) -- Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today …See details»
Aaron Cravens, CEO of Revel Pharmaceuticals at the ... - Reddit
Aaron co-founded Revel in 2019 inspired by the potential impact anti-AGE therapeutics could have on patients. He is thrilled to lead development of the team and technology that will take …See details»